Phone: 508-754-1791 | Fax: 508-795-0813 Open: Monday-Friday 9AM-6PM

Boswellia AKBA (Pure Encapsulations)

Boswellia AKBA (Pure Encapsulations)

$32.99 - $58.99

Boswellia AKBA supports the structural integrity, motility and comfort of joint cartilage and promotes gastrointestinal health and cell health, primarily by maintaining healthy 5-lipoxygenase activity.*

  • Supports joint structure, longevity and comfort*
  • Contains 5-LOXIN®, a patent pending boswellia extract providing ten times as much AKBA as typical boswellia extracts
  • Made with hypoallergenic, vegan ingredients

5–LOXIN® is a patent pending boswellia extract providing ten times as much AKBA as typical boswellia extracts. In studies, 5–LOXIN® has demonstrated the potential to support joint motility and comfort, in part by promoting a healthy immune response. It may also play a role in maintaining healthy matrix metalloproteinase (MMP) activity, supporting connective tissue structural composition. Additionally, a randomized double blind study involving 102 individuals revealed that AKBA supports gastrointestinal health. Further studies have indicated that AKBA may provide gastrointestinal support by maintaining healthy immune activity in the endothelial lining of the digestive tract. Moreover, studies suggest AKBA supports healthy cell signaling and cell cycle function for high capacity cellular support.*


Take 1 capsule daily, with a meal.


Serving Size: One Vegetarian Capsule

Amount Per Serving
5-LOXIN® Boswellia Serrata Extract ... 100mg
Indian Frankincense Extract ... 30mg
(boswellia serrata)(gum resin)
(standardized to contain 30% 3-acetyl-11-keto-beta-boswellic acid (AKBA))

Other Ingredients: hypoallergenic plant fiber (cellulose), ascorbyl palmitate, vegetarian capsule (cellulose, water)


Not to be taken by pregnant or lactating women. Consult a health professional before taking this or any other product.

Rare side effects of boswellia include diarrhea, skin rash, acid reflux and nausea and may be contraindicated in those with pre-existing gastritis or gastro-esophageal reflux disease (GERD).

Studies suggest boswellia moderates 5-lipoxygenase and therefore may interact
with leukotriene inhibitors.